Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AbbVie and Teneobio to co-develop new drug for multiple myeloma

pharmaceutical-technologyFebruary 13, 2019

Tag: AbbVie , Teneobio , multiple myeloma , TNB-383B

PharmaSources Customer Service